1. Home
  2. DTCK vs IGC Comparison

DTCK vs IGC Comparison

Compare DTCK & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTCK
  • IGC
  • Stock Information
  • Founded
  • DTCK 1999
  • IGC 2005
  • Country
  • DTCK Singapore
  • IGC United States
  • Employees
  • DTCK N/A
  • IGC N/A
  • Industry
  • DTCK Farming/Seeds/Milling
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTCK Industrials
  • IGC Health Care
  • Exchange
  • DTCK Nasdaq
  • IGC Nasdaq
  • Market Cap
  • DTCK 19.3M
  • IGC 20.2M
  • IPO Year
  • DTCK 2023
  • IGC N/A
  • Fundamental
  • Price
  • DTCK N/A
  • IGC $0.31
  • Analyst Decision
  • DTCK
  • IGC Strong Buy
  • Analyst Count
  • DTCK 0
  • IGC 2
  • Target Price
  • DTCK N/A
  • IGC $3.88
  • AVG Volume (30 Days)
  • DTCK 3.7M
  • IGC 232.1K
  • Earning Date
  • DTCK 04-30-2025
  • IGC 08-07-2025
  • Dividend Yield
  • DTCK N/A
  • IGC N/A
  • EPS Growth
  • DTCK N/A
  • IGC N/A
  • EPS
  • DTCK N/A
  • IGC N/A
  • Revenue
  • DTCK $132,369,000.00
  • IGC $1,271,000.00
  • Revenue This Year
  • DTCK N/A
  • IGC $15.26
  • Revenue Next Year
  • DTCK N/A
  • IGC $3.41
  • P/E Ratio
  • DTCK N/A
  • IGC N/A
  • Revenue Growth
  • DTCK N/A
  • IGC N/A
  • 52 Week Low
  • DTCK $0.40
  • IGC $0.25
  • 52 Week High
  • DTCK $1.50
  • IGC $0.50
  • Technical
  • Relative Strength Index (RSI)
  • DTCK 54.17
  • IGC 44.22
  • Support Level
  • DTCK $0.78
  • IGC $0.30
  • Resistance Level
  • DTCK $0.91
  • IGC $0.32
  • Average True Range (ATR)
  • DTCK 0.18
  • IGC 0.01
  • MACD
  • DTCK -0.01
  • IGC -0.00
  • Stochastic Oscillator
  • DTCK 10.08
  • IGC 0.00

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: